Urology Devices Market by Product (Dialysis, Laser, Lithotripsy, Robotic, Insufflators, Guidewires, Catheters, Stents, Implants), Application (Kidney Diseases, Cancer, Pelvic Organ Prolapse, BPH, Stones), End User and Region - Global Forecast to 2030

The global urology devices market is valued at an estimated USD 34.56 billion in 2025 and is projected to reach USD 46.26 billion by 2030, at a CAGR of 6.0% during the forecast period. The rising prevalence of chronic metabolic and cardiovascular diseases, including diabetes mellitus and hypertension, has significantly escalated the incidence of urological pathologies that necessitate prompt diagnostic assessment and surgical intervention. Immediate and evidence-based clinical management is essential to prevent disease progression and optimize patient outcomes. Concurrently, the accelerating adoption of minimally invasive urological techniques, encompassing robotic-assisted procedures, endoscopic interventions, and percutaneous therapies, has substantially increased the demand for precision urology devices that ensure procedural safety, diagnostic accuracy, and therapeutic efficacy.

The consumables & accessories segment is projected to register the fastest growth rate in the urology devices market, by product category, during the forecast period.

The urology devices market is bifurcated into instruments and consumables & accessories based on product. The consumables & accessories segment is expected to expand at a higher compound annual growth rate. The high growth rate of the consumables & accessories segment is due to increased research and development initiatives focused on developing innovative solutions for managing the rising prevalence of chronic urological diseases. Additionally, the growing emphasis on reusable consumables, device standardization, and procedural efficiency has increased demand for consumables across hospitals, surgical centers, and outpatient facilities globally.

The dialysis centers segment is projected to register the highest growth rate in the urology devices market.

Based on end users, the urology devices market is segmented into hospitals, ASCs, clinics, dialysis centers, and home care settings. Dialysis centers are experiencing the highest growth rate. This accelerated growth can be attributed to the substantially increased demand for advanced dialysis equipment and specialized facilities required for managing end-stage renal disease (ESRD). The rising prevalence of chronic kidney disease globally, coupled with the escalating incidence of diabetes and hypertension driving renal failure cases, has created urgent demand for more dialysis centers and upgraded facility infrastructure. Additionally, technological advancements in dialysis technology, improved treatment protocols, and growing patient awareness are collectively driving investment in new dialysis facilities and modern equipment, thereby propelling the dialysis centers segment to emerge as the fastest-growing end-user category in the global urology devices market.

Asia Pacific is expected to be the fastest-growing region in the global urology devices market.

The Asia Pacific region is projected to register the highest CAGR during the forecast period. This accelerated regional growth is propelled by multiple interconnected factors, including the substantially rising geriatric population requiring advanced urological interventions, escalating prevalence of kidney disease, significant disease burden from chronic kidney disease (CKD) affecting millions across the region, rapidly increasing healthcare spending and per capita income levels, growing consumer demand for therapeutic technologies, strategic expansion of private-sector hospital networks into underserved rural areas across Asia Pacific countries, and the presence of emerging high-growth markets with untapped potential. Additionally, improvements in healthcare accessibility, government initiatives supporting the development of healthcare infrastructure, and rising patient awareness of advanced urological treatment options are collectively positioning the Asia Pacific region as the most dynamic and fastest-growing market for urology devices globally.

Breakdown of supply-side primary interviews, by company type, designation, and region:

• By Company Type: Tier 1 (40%), Tier 2 (30%), and Tier 3 (20%)
• By Designation: C Level (27%), Director Level (18%), and Others (55%)
• By Region: North America (51%), Europe (21%), Asia Pacific (18%), Latin America (6%), and Middle East & Africa (4%)

List of Companies Profiled in the Report

• Fresenius Medical Care AG & Co. KGaA (Germany)
• Boston Scientific Corporation (US)
• Becton, Dickinson and Company (US)
• B. Braun Melsungen AG (Germany)
• Cardinal Health (US)
• Olympus Corporation (Japan)
• Intuitive Surgical (US)
• Coloplast A/S (Denmark)
• Stryker Corporation (US)
• Teleflex Incorporated (US)
• Convatec Group PLC (UK)
• Medtronic PLC (Ireland)
• Karl Storz (Germany)
• Cook Medical (US)
• Richard Wolf GmbH (Germany)
• CompactCath (US)
• Dornier MedTech (Germany)
• Well Lead Medical Co., Ltd. (China)
• ROCAMED (Germany)
• Amniso International, Inc. (US)
• Medispec (US)
• Vimex Sp. z o.o. (Poland)
• Balton Sp. z o.o. (Poland)
• Hunter Urology (UK)
• Ribbel International Ltd. (India)

Research Coverage

This research report categorizes the urology devices market by product (instruments and consumables & accessories), application (kidney diseases, urological cancer, pelvic organ prolapse, benign prostatic hyperplasia, urinary incontinence, erectile dysfunction, urinary stones and other applications), end user (hospitals, ASCS & clinics, dialysis centers and home care settings), and region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, opportunities, and challenges, influencing the growth of the urology devices market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions and services, key strategies, acquisitions, and agreements. New product launches and recent developments associated with the urology devices market. Competitive analysis of upcoming startups in the urology devices market ecosystem is covered in this report.

Key Benefits of Buying the Report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall urology devices market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights into the following pointers:

• Analysis of key drivers (Rising incidence of urological diseases, Growing preference for minimally invasive procedures, Technological advancements and increased R&D investments, Increasing number of hospitals and surgical centers) restraints (High degree of consolidation among key players), opportunities (Potential growth opportunities in emerging economies) and challenges (Increasing number of product recalls by key players, Shortage of urologists and trained professionals) influencing the growth of the urology devices market
• Product Development/Innovation: Detailed insights into upcoming technologies, research & development activities, and new product launches in the urology devices market.
• Market Development: Comprehensive information about lucrative markets – the report analyzes the urology devices market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the urology devices market
• Competitive Assessment: In-depth assessment of market shares, growth strategies and product offerings of leading players, such as Fresenius Medical Care AG & Co. KGaA (Germany), Cardinal Health (US), Boston Scientific Corporation (US), Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), among others in the urology devices market strategies.

Show more